Musolino A - Search Results

1

Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review.

Pellegrino B, Boggiani D, Tommasi C, Palli D, Musolino A. Pellegrino B, et al. Among authors: musolino a. Acta Biomed. 2017 Oct 23;88(3):329-333. doi: 10.23750/abm.v88i3.6138. Acta Biomed. 2017. PMID: 29083340 Free PMC article. Review.

2

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.

Musolino A, Boggiani D, Panebianco M, Vasini G, Salvagni S, Franciosi V, Ardizzoni A. Musolino A, et al. Cancer. 2011 Mar 1;117(5):964-73. doi: 10.1002/cncr.25582. Epub 2010 Oct 19. Cancer. 2011. PMID: 20960528 Free article. Clinical Trial.

3

Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study.

Musolino A, Michiara M, Conti GM, Boggiani D, Zatelli M, Palleschi D, Bella MA, Sgargi P, Di Blasio B, Ardizzoni A. Musolino A, et al. J Clin Oncol. 2012 Jul 1;30(19):2362-8. doi: 10.1200/JCO.2011.37.6434. Epub 2012 May 14. J Clin Oncol. 2012. PMID: 22585698

4

Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers.

Musolino A, Boggiani D, Sikokis A, Rimanti A, Pellegrino B, Vattiato R, Sgargi P, Falcini F, Caminiti C, Michiara M, Leonardi F. Musolino A, et al. Cancer Treat Rev. 2016 Feb;43:1-7. doi: 10.1016/j.ctrv.2015.11.010. Epub 2015 Dec 7. Cancer Treat Rev. 2016. PMID: 26827687 Review.

5

Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.

Pellegrino B, Bella M, Michiara M, Zanelli P, Naldi N, Porzio R, Bortesi B, Boggiani D, Zanoni D, Camisa R, Neri TM, Pinto C, Musolino A. Pellegrino B, et al. Among authors: musolino a. Acta Biomed. 2016 May 6;87(1):54-63. Acta Biomed. 2016. PMID: 27163896

6

FCGR, Cetuximab, and Colorectal Cancer Survival-Letter.

Negri FV, Boggiani D, Rimanti A, Musolino A. Negri FV, et al. Among authors: musolino a. Clin Cancer Res. 2016 Oct 1;22(19):4958. doi: 10.1158/1078-0432.CCR-16-1470. Clin Cancer Res. 2016. PMID: 27697992 No abstract available.

7

My best choice after a round trip from illness.

Tommasi C, Pellegrino B, Quaini F, Musolino A. Tommasi C, et al. Among authors: musolino a. Acta Biomed. 2017 Aug 23;88(2):196-197. doi: 10.23750/abm.v88i2.5777. Acta Biomed. 2017. PMID: 28845836 Free PMC article.

8

Prognostic Role of Immunoglobulin G Fragment C Receptor Polymorphisms in Solid Tumors.

Viansone AA, Boggiani D, Musolino A. Viansone AA, et al. Among authors: musolino a. JAMA Oncol. 2018 Jan 1;4(1):132. doi: 10.1001/jamaoncol.2017.2802. JAMA Oncol. 2018. PMID: 28973387 No abstract available.

9

Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review.

Militello AM, Zielli T, Boggiani D, Michiara M, Naldi N, Bortesi B, Zanelli P, Uliana V, Giuliotti S, Musolino A. Militello AM, et al. Among authors: musolino a. Front Oncol. 2019 Aug 13;9:759. doi: 10.3389/fonc.2019.00759. eCollection 2019. Front Oncol. 2019. PMID: 31456944 Free PMC article.

10

Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis.

Pellegrino B, Mazzaschi G, Madeddu D, Mori C, Lagrasta CAM, Missale G, Quaini F, Musolino A. Pellegrino B, et al. Among authors: musolino a. Front Oncol. 2020 Feb 25;10:192. doi: 10.3389/fonc.2020.00192. eCollection 2020. Front Oncol. 2020. PMID: 32158689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters